Stock Analysis·← Pickers

LFWD

Lifeward Ltd.

Lifeward Ltd. (LFWD) is currently in a range/mixed trend, trading above both the 50-day and 200-day moving averages. RSI is at 53.1, with 2/3 trend checks passing.

Price
$7.81
2026-07-16
Trend score
2/3
Range / Mixed
RSI (14)
53.1
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

LFWD with MA50 and MA200

11.259.587.926.254.5907/3110/2401/2204/1707/15
LFWD2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$7.23+8.09% vs price
MA200
$7.30+6.93% vs price
RSI (14)
53.1Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
$6.00–$6.2420.1% below price · 5 touches
Support Quality
5 touches1.5× zone volume
Chart Summary
Trend summary for LFWD

Lifeward Ltd. (LFWD) looks more range-bound than strongly trending, but there are still a few supportive signs on the chart. The latest available price is $7.81, and 2 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 8.1% and above the 200-day moving average by 6.9%.

Momentum and stretch context

LFWD currently has an RSI reading of 53.1, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

This page is designed to help you quickly understand what the LFWD chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Lifeward Ltd.

Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.

Sector
Healthcare
Industry
Medical - Devices
CEO
William Mark Grant
Employees
81
Market cap
$12.6M
Beta
0.37
52-week range
$4.14 – $10.56
Dividend
No
Exchange
NASDAQ
Country
IL
IPO date
12 Sept 2014
ISIN
IL0011331076
CUSIP
M8216Q309
Company profile data from Financial Modeling Prep. LFWD listed on NASDAQ.
Share dilution

LFWD shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2021Mar 2026
Shares outstanding (latest)
1.6M
Since Jun 2021
+193.5%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. LFWD20 data points from Jun 2021 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about LFWD

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.

LFWD Stock Analysis: Range/Mixed trend, above MA50 & MA200, RSI 53 | MyStockHarbor